“CLINICAL TRIAL” APPROVAL

In collaboration with IRCCS – Istituto Tumori Giovanni Paolo II in Bari, Italy, it has been approved to conduct clinical trials to study the analytical performance of the Single- Molecule with a large Transistor (SiMoT) device. This study will allow…


